SE8900828L - Antivirala och immunstimulerande farmaceutiska kompositioner samt foerfarande foer framstaellning av desamma - Google Patents
Antivirala och immunstimulerande farmaceutiska kompositioner samt foerfarande foer framstaellning av desammaInfo
- Publication number
- SE8900828L SE8900828L SE8900828A SE8900828A SE8900828L SE 8900828 L SE8900828 L SE 8900828L SE 8900828 A SE8900828 A SE 8900828A SE 8900828 A SE8900828 A SE 8900828A SE 8900828 L SE8900828 L SE 8900828L
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutical compositions
- antiviral
- immunstimulating
- procedures
- preparing
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 150000004665 fatty acids Chemical class 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 229960001438 immunostimulant agent Drugs 0.000 abstract 1
- 239000003022 immunostimulating agent Substances 0.000 abstract 1
- 230000003308 immunostimulating effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU881132A HU209973B (en) | 1988-03-09 | 1988-03-09 | Process for production of antiviral and immunstimular pharmaceutical composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8900828D0 SE8900828D0 (sv) | 1989-03-09 |
| SE8900828L true SE8900828L (sv) | 1989-09-10 |
Family
ID=10952974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8900828A SE8900828L (sv) | 1988-03-09 | 1989-03-09 | Antivirala och immunstimulerande farmaceutiska kompositioner samt foerfarande foer framstaellning av desamma |
Country Status (14)
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU210122B (en) * | 1988-03-23 | 1995-02-28 | Biorex Kutato Fejlesztoe Kft | Process for production of composition against thromboembolytic conditions of circulating system and heart |
| JPH04279523A (ja) * | 1991-01-11 | 1992-10-05 | Nisshin Flour Milling Co Ltd | 免疫賦活油脂加工品 |
| GB9304746D0 (en) * | 1993-03-09 | 1993-04-28 | Scotia Holdings Plc | Treatment of viral infections |
| EP0690709A1 (en) * | 1993-03-26 | 1996-01-10 | DINU, Constantin Romulus | Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation |
| GB9318611D0 (en) * | 1993-09-08 | 1993-10-27 | Sandoz Nutrition Ltd | Improvements in or relating to organic compounds |
| WO1995009622A1 (en) * | 1993-10-06 | 1995-04-13 | Peptide Technology Limited | Polyunsaturated fatty acids and uses thereof |
| IT1264987B1 (it) * | 1993-12-14 | 1996-10-17 | Prospa Bv | Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono |
| AUPM906594A0 (en) * | 1994-10-26 | 1994-11-17 | Peptide Technology Limited | Synthetic polyunsaturated fatty acid analogues |
| DE19503993A1 (de) * | 1995-02-08 | 1996-08-14 | Johann Friedrich Dr Med Desaga | Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen |
| US5639858A (en) * | 1995-03-22 | 1997-06-17 | Tularik, Inc. | Human signal transducer and binding assays |
| WO1996030381A1 (en) * | 1995-03-28 | 1996-10-03 | Novo Nordisk A/S | Immunosuppressive agents |
| HU227588B1 (hu) * | 2004-12-03 | 2011-09-28 | Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft | Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény |
| WO2009079544A1 (en) * | 2007-12-17 | 2009-06-25 | University Of Florida Research Foundation, Inc. | Materials and methods for treatment of pathological ocular vascular proliferation |
| FR3031451B1 (fr) * | 2015-01-13 | 2018-03-23 | Greentech | Sel d'un triglyceride, preparation et utilisations |
| US12115260B2 (en) | 2016-05-25 | 2024-10-15 | Evonik Operations Gmbh | Tablets with high active ingredient content of omega-3 fatty acid amino acid salts |
| EP3248467A1 (de) * | 2016-05-25 | 2017-11-29 | Evonik Technochemie GmbH | Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze |
| EP3648748A1 (en) | 2017-07-06 | 2020-05-13 | Evonik Operations GmbH | Enteric coated solid dosage form comprising omega-3 fatty acid amino acid salts |
| US11622952B2 (en) | 2017-08-15 | 2023-04-11 | Evonik Operations Gmbh | Tablets with high active ingredient content of omega-3 fatty acid amino acid salts |
| US20220280387A1 (en) | 2019-08-08 | 2022-09-08 | Evonik Operations Gmbh | Down streaming process for the production of polyunsaturated fatty acid salts |
| EP4009961A1 (en) | 2019-08-08 | 2022-06-15 | Evonik Operations GmbH | Solubility enhancement of poorly soluble actives |
| DE102022003441A1 (de) | 2022-09-17 | 2024-03-28 | Jutta Ibrahim | Nahrungsergänzungsmittel Omega3 und essentielle Aminosäure(n) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1256162A (en) * | 1968-08-16 | 1971-12-08 | Braun Fa B | Improvements in and relating to liquid products for intravenous administration |
| FR2215212B1 (enrdf_load_stackoverflow) * | 1973-01-18 | 1976-03-05 | Seperic Ch | |
| FR2508797B1 (fr) * | 1981-07-03 | 1986-03-14 | Charles Chany | Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique |
| GB2118437B (en) * | 1982-03-01 | 1984-12-12 | Efamol Ltd | Composition for treating alcoholism |
| US4513008A (en) * | 1982-07-30 | 1985-04-23 | The Vinoxen Company, Inc. | Virucidal compositions and therapy |
| DE3229956A1 (de) * | 1982-08-12 | 1984-02-16 | Erichsen, Friedrich Karl, Dr., 2351 Schillsdorf | Arzneimittel mit cytostatischer wirkung |
| DE3514328C1 (de) * | 1985-04-19 | 1986-09-11 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, 6900 Heidelberg | Verwendung von L-Ornithin bei der selektiven Hemmung von cytotoxischen T-Lymphozyten-Effektorzellen |
| WO1988001861A1 (en) * | 1986-09-17 | 1988-03-24 | Baxter Travenol Laboratories, Inc. | Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic, vascular, cardiovascular, and/or thrombotic diseases |
| EP0310639B1 (en) * | 1987-02-20 | 1993-03-03 | Shriners Hospitals For Crippled Children | Omega-3 fatty acids in traumatic injury treatment |
| DE3726299A1 (de) * | 1987-06-26 | 1989-02-23 | Dietl Hans | Fettemulsion zur intravenoesen anwendung |
-
1988
- 1988-03-09 HU HU881132A patent/HU209973B/hu unknown
-
1989
- 1989-03-06 CH CH819/89A patent/CH678918A5/de not_active IP Right Cessation
- 1989-03-09 SE SE8900828A patent/SE8900828L/xx not_active Application Discontinuation
- 1989-03-09 BE BE8900254A patent/BE1002890A3/fr not_active IP Right Cessation
- 1989-03-09 GB GB8905385A patent/GB2216418B/en not_active Expired - Fee Related
- 1989-03-09 JP JP1055242A patent/JPH01316316A/ja active Pending
- 1989-03-09 FI FI891145A patent/FI94591C/fi not_active IP Right Cessation
- 1989-03-09 DE DE3907649A patent/DE3907649C2/de not_active Expired - Fee Related
- 1989-03-09 IT IT8919704A patent/IT1229562B/it active
- 1989-03-09 CA CA000593270A patent/CA1334576C/en not_active Expired - Fee Related
- 1989-03-09 FR FR8903085A patent/FR2628324B1/fr not_active Expired - Fee Related
- 1989-03-09 LU LU87471A patent/LU87471A1/fr unknown
- 1989-03-09 NL NL8900574A patent/NL8900574A/nl not_active Application Discontinuation
- 1989-03-09 KR KR1019890002920A patent/KR890014103A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| IT8919704A0 (it) | 1989-03-09 |
| FI891145L (fi) | 1989-09-10 |
| DE3907649C2 (de) | 1996-07-11 |
| GB8905385D0 (en) | 1989-04-19 |
| GB2216418B (en) | 1991-12-11 |
| FI94591C (fi) | 1995-10-10 |
| FR2628324A1 (fr) | 1989-09-15 |
| HU209973B (en) | 1995-01-30 |
| GB2216418A (en) | 1989-10-11 |
| JPH01316316A (ja) | 1989-12-21 |
| FI891145A0 (fi) | 1989-03-09 |
| FR2628324B1 (fr) | 1994-05-27 |
| BE1002890A3 (fr) | 1991-07-16 |
| KR890014103A (ko) | 1989-10-21 |
| CH678918A5 (enrdf_load_stackoverflow) | 1991-11-29 |
| LU87471A1 (fr) | 1990-10-02 |
| NL8900574A (nl) | 1989-10-02 |
| FI94591B (fi) | 1995-06-30 |
| DE3907649A1 (de) | 1989-09-28 |
| CA1334576C (en) | 1995-02-28 |
| SE8900828D0 (sv) | 1989-03-09 |
| HUT60432A (en) | 1992-09-28 |
| IT1229562B (it) | 1991-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8900828L (sv) | Antivirala och immunstimulerande farmaceutiska kompositioner samt foerfarande foer framstaellning av desamma | |
| ES541521A0 (es) | Un procedimiento para la preparacion de piridazinaminas. | |
| GR3030124T3 (en) | Derivatives of cyclohexane, preparations containing them and their use | |
| GEP19960467B (en) | Method of producing derivatives of quinoline or their pharmaceutically acceptable esters or acid-additive salts | |
| GB1463966A (en) | Depilatory formulation | |
| BG92179A (bg) | Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения | |
| AU639717B2 (en) | 24-homo vitamin d derivatives, process for their production and pharmaceutical preparations obtained therefrom | |
| SE8901041D0 (sv) | Antitrombotiska farmaceutiska preparat samt foerfarande foer deras framstaellning | |
| ES8704957A1 (es) | Procedimiento para preparar alfa-aminoacidos sustituidos | |
| GB1298494A (en) | Phenylethanolamine derivatives | |
| ES460098A1 (es) | Metodo para producir derivados de acido penicilanico. | |
| ES8401960A1 (es) | Procedimiento para la preparacion de imidazolilfenil-tetrahidropiridazinas. | |
| ES8505518A1 (es) | Procedimiento para preparar derivados de aminoacidos | |
| HUT40126A (en) | Process for producing 6,7-disubstituted-1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphtiridine-3-carboxylic acid derivatives and pharmaceutical compositions and food additives containing them | |
| SE8900827D0 (sv) | Nya foereningar av salttyp samt foerfarande foer framstaellning av desamma | |
| GB1285400A (en) | Esters of substituted anthranilic acid | |
| GB1308028A (en) | Thiazolylbenzoic acid derivatives and a process for their manufactur | |
| PT81229B (pt) | Processo para a preparacao de 1,3-dimetil-1h-purino-2,6-dionas contendo 1h-indol-3-ilo e de composicoes farmaceuticas contendo estes compostos | |
| GB1271466A (en) | Thiocarbamic acid derivatives | |
| GB1097531A (en) | Improvements in or relating to the preparation of cyclopentane derivatives | |
| GB1185096A (en) | Improvements in or relating to Antibiotic Derivatives and the manufacture thereof | |
| MY105684A (en) | Skin detergent composition | |
| ES8104222A1 (es) | Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo (3,2,0) hept-2-en-2-carboxilico | |
| SE8800988D0 (sv) | Pharmaceutical compositons acting on the heart and cardiovascular system and process for preparing same | |
| ES483087A1 (es) | Procedimiento para la obtencion de bencimidazolcarbamatos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8900828-8 Effective date: 19940325 Format of ref document f/p: F |